O-GlcNAc as a potential target for disease modifying therapy in Alzheimer disease

被引：0

作者：

Vocadlo, David J. ^{[1
,2
]}

Yuzwa, Scott A. ^{[1
]}

Shan, Xiaoyang ^{[2
]}

Heinonen, Julia ^{[1
]}

Watson, Neil ^{[3
]}

Jones, Bryan ^{[3
]}

Macauley, Matthew S. ^{[1
]}

Gong, Chengxin ^{[4
]}

McEachern, Ernest ^{[1
]}

Yadav, Anuj ^{[1
]}

机构：

[1] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada

[2] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada

[3] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada

[4] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

215-MEDI

引用

页数：1

共 50 条

[41] Therapeutic Potential of O-GlcNAc Glycosylation Related Signaling Pathways
Schmitz, Brigitte
CURRENT SIGNAL TRANSDUCTION THERAPY, 2010, 5 (01) : 1 - 2
[42] Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus The Role of Protein O-GlcNAc Modification
Chen, Yabing
Zhao, Xinyang
Wu, Hui
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (10) : 1911 - 1924
[43] Deciphering the 'O-GlcNAc code': Lessons from C. elegans and human disease
Hanover, John A.
GLYCOBIOLOGY, 2006, 16 (11) : 1105 - 1105
[44] Hexosamine biosynthetic pathway and O-GlcNAc cycling of glucose metabolism in brain function and disease
Kim, Dong Yeol
Park, Jiwon
Han, Inn-Oc
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2023, 325 (04): : C981 - C998
[45] Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer’s disease
Swetaleena Shaw
Pratyush Porel
Khadga Raj Aran
Molecular Biology Reports, 2025, 52 (1)
[46] Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease
Bateman, Randall J.
Klunk, William E.
NEUROTHERAPEUTICS, 2008, 5 (03) : 381 - 390
[47] Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease
Beher, D
Graham, SL
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (11) : 1385 - 1409
[48] Targeting Neuroinflammation as Disease Modifying Approach to Alzheimer's Disease: Potential and Challenges
Jain, Smita
Singh, Ritu
Paliwal, Sarvesh
Sharma, Swapnil
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (22) : 2097 - 2116
[49] Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease
Randall J. Bateman
William E. Klunk
Neurotherapeutics, 2008, 5 : 381 - 390
[50] Overview of potential targets for disease-modifying drugs in Alzheimer's disease
Cuello, A. Claudio
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 4 - 4

← 1 2 3 4 5 →